Is Akebia Therapeutics, Inc. (AKBA) a Buy, Sell, or Hold?
NASDAQ : AKBA
Akebia Therapeutics, Inc.
$1.34 USD
-$0.06 (-4.29%)
- Volume
- 2.52M
- Average Volume
- 5.12M
- Market Capitalization
- $359.47M
- P/E Ratio
- -17.38
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $4.04
- Year Low
- $0.82
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.40
Analyst Consensus Summary
Consensus Rating
Strong Sell
11 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-66.5%
vs Current Price
Price Target
$4.00
Average TargetPrice Target Range
Lowest Target
$4.00
-66.5% DOWNSIDE
Average Target
$4.00
Median Estimate
Highest Target
$4.00
-66.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 11
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 7 | 3 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Piper Sandler | Allison Bratzel | $4 | $1.38 | 2026-02-06 06:51 AM | 189.9% |
| H.C. Wainwright | Ed Arce | $6 | $1.98 | 2024-03-28 08:08 AM | 203.0% |
| Needham | Serge Belanger | $7 | $2.65 | 2022-03-02 07:00 PM | 164.2% |